Approval · Notice of Compliance 26101 · 2021
CEFA-LAK: Notice of Compliance 26101
Issued June 18, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26101
- Date
- June 18, 2021
- Company
- Boehringer Ingelheim Animal Health Canada Inc.Burlington, Ontario, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in product ownersip
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CEFA-LAK | 02173263 | Marketed |
Medicinal ingredients
- CEPHAPIRIN SODIUM 200 MG per 10ML